Skip to main content
Premium Trial:

Request an Annual Quote

HTG

Premium
HTG recently introduced its quantitative Nuclease Protection Assay, an in situ testing method for gene expression in formalin-fixed, paraffin-embedded tissue samples.
 

According to HTG, the assay enables researchers to quantitate RNA expression for up to 16 targets simultaneously in FFPE tissue sections without the need for extraction or target amplification. The qNP assay is designed to run on HTG’s ArrayPlate platform.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.